Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial - Reich, K; Teixeira, HD; de Bruin-Weller, M (Lancet, 2021)
et al.